Knowledge. Hope. Community.
Across all breast cancer subtypes,…
https://www.mbcalliance.org/wp-content/uploads/BRAIN-METS-scaled.jpg14402560Corti Cooperhttps://www.mbcalliance.org/wp-content/uploads/mbca-logo.pngCorti Cooper2024-02-14 16:11:222024-02-15 09:30:55What’s New in Breast Cancer Brain Metastasis Support
The FDA approved Truqap plus Faslodex for the treatment of metastatic…
https://www.mbcalliance.org/wp-content/uploads/2024.02.09-FORCE-HR.jpg267400Dana Mooneyhttps://www.mbcalliance.org/wp-content/uploads/mbca-logo.pngDana Mooney2024-02-09 15:00:062024-03-21 15:45:50New drug combination for the second treatment of some HR-positive advanced breast cancers
When it comes to transforming the lives of people living with…
https://www.mbcalliance.org/wp-content/uploads/Terri-SABCS-Crop.png6301200Corti Cooperhttps://www.mbcalliance.org/wp-content/uploads/mbca-logo.pngCorti Cooper2024-02-05 09:03:332024-02-06 23:14:06Notes from a Patient Advocate on SABCS 2023
To support the wellbeing and outcomes of people living with metastatic…
https://www.mbcalliance.org/wp-content/uploads/UFH-IMAGE-REDO-scaled-e1707267789792.jpg6751200Corti Cooperhttps://www.mbcalliance.org/wp-content/uploads/mbca-logo.pngCorti Cooper2024-01-09 10:19:422024-06-12 00:10:09Integrative Care Provides Significant Benefit to People with Metastatic Breast Cancer
What’s New in Breast Cancer Brain Metastasis Support
NewsNew drug combination for the second treatment of some HR-positive advanced breast cancers
FORCE Syndicated ContentMBC Research Funding Analysis
News, ResearchNotes from a Patient Advocate on SABCS 2023
Guest Blog PostsIntegrative Care Provides Significant Benefit to People with Metastatic Breast Cancer
News